Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 599 results for "reddy"

Indian ADRs: Dr Reddy#39;s Lab, Tata Motors, Infosys up; ICICI Bank down
Money Control

Stocks 360: Here#39;s a 360 degree view on Divis Lab Dr Reddys

Watch CNBC-TV18’s Ekta Batra give a 360 degree round up on Divis Laboratories and Dr Reddys Laboratories. Money Control, 2 hours ago

685 images for reddy

Money Control, 20 hours ago
Money Control, 4 days ago
DNA, 5 days ago
Money Control, 4 days ago
DNA, 5 days ago
India Today, 5 days ago
Mathrubhumi, 4 days ago
Money Control, 6 days ago
Money Control, 1 week ago
DNA, 1 week ago

Sensex ends flat in cautious trade

Among major gainers, ITC, Reliance Industries, Dr Reddy's and HDFC rose up to 3 per cent. The benchmark BSE Sensex ended flat at 32,400.51 points after a range-bound trade as investors awaited the US Federal Reserve's policy decision for further direction. After opening higher at 32,467.10 points, the Sensex slipped into the negative zone to touch a low of 32,383.82 in day trade.   The 30-share index finally settled down 1.86 points, or 0.01 per cent, at 32,400.51. The gauge had lost ...
 Rediff.com3 hours ago Sensex Opens Flat; Dr Reddy's Lab Rallies 6.8%  Equitymaster.com2 weeks ago Sensex gains 162 points as September F&O starts strong  Rediff.com2 weeks ago Sensex, Nifty end flat; Sun Pharma, Dr Reddy's Lab up  Myiris3 weeks ago
Money Control

CLSA sees risk reward turning favourable for Dr Reddy#39;s Labs; stock up 3%

The global broking firm also observed that three products, Nuvaring, Suboxone Copaxone will be major contributors over FY19-20. In fact, the EPS for FY20 could see an upside of 44 percent to Rs 210 if these products are introduced.
 Money Control6 hours ago

Market Live: Nifty hovers around 10,150 ahead of Fed meet outcome; Dr Reddy#39;s up

Telecom stocks - Bharti Airtel, Idea Cellular and Reliance Communications fell 3-6 percent after telecom regulator TRAI slashed mobile call connection charge to 6 paise per minute from 14 paise currently, effective October 1.
 Money Control6 hours ago

Why should only petro consumers pay for infra projects: Reddy

Former oil minister S Jaipal Reddy has questioned the Centre's policy of utilising its revenues from petroleum products for infrastructure projects, saying the high prices of diesel and petrol are hitting the middle class hard. "Why should only the consumers ...
 Business Standard1 day ago
Daiji World

Cop slaps driver; minister orders action

Home Minister Ramalinga Reddy has directed Bengaluru City Police Commissioner T Sunil Kumar and Additional Commissioner of Police (Traffic) R Hithendra to act sternly against traffic police officials who misbehaved with a driver. Reddy took note of the video ...
 Deccan Herald2 days ago Scribe murder probe: Nothing revealed so far, says minister  Business Standard1 week ago Free Bengaluru from rowdies, home minister tells cops  Deccan Herald1 week ago Kempaiah still calling shots in Home affairs, says HDK  Deccan Herald1 week ago

Indian doctor Achutha Reddy stabbed to death in US; colleagues, patients mourn 'tragic loss'

Achutha Reddy, who hailed from Telengana, was hacked to death at his clinic in East Wichita on Wednesday.
 DNA5 days ago Murder suspect was sent to India to straighten out: Report  Prokerala5 days ago Telangana doctor stabbed to death near his clinic in Kansas, patient arrested  India Today5 days ago Indian doctor from Telangana stabbed to death in US  Rediff.com5 days ago
Money Control

Pharma wrap: Dr Reddy#39;s German observation, Cadila clearing US inspection more

The sector was kept busy with Dr Reddy#39;s German regulator observations, Cadila Healthcare clearing US FDA inspection with zero observations, Biocon getting EU-GMP for Malaysia insulins facility and Novartis naming Indian-origin Vas Narasimhan as its CEO.
 Money Control1 week ago Dr Reddy#39;s plunges 7% on 6 major observations from German regulator for Duvvada unit  Money Control1 week ago Regulatory woes resurface for Dr Reddy's  Business Standard1 week ago Duvvada unit audit: Dr Reddy's to launch corrective plan post verdict  Business Standard1 week ago
Money Control

Divis Labs extend gains from Tuesday; other pharma stocks rally too

Sun Pharmaceuticals and Dr Reddy’s Laboratories gained around 2 percent intraday.
 Money Control1 week ago Closing bell: Sensex gains 162 pts, Midcap outperforms Nifty; autos, pharma lead  Money Control2 weeks ago Pharma weekly wrap: Stocks rebound on low valuations, Dr Reddy#39;s slapped with lawsuit  Money Control3 weeks ago Major pharmaceutical stocks gain big as investors scout for value buys  Money Control3 weeks ago

Dr Reddy's gets healthier after arm starts phase II trials of cancer drug

Dr Reddy's Laboratories gained 1.89% to Rs 2,205.65 at 11:00 IST on BSE after the company said that its wholly owned subsidiary has started phase II trials of cancer drug.
 Business Standard1 week ago Dr Reddy's needs to take lead in corporate governance: Analysts  Business Standard3 weeks ago Class action lawsuit filed against Dr Reddy's in US over violations of American federal securities laws  DNA3 weeks ago Dr Reddy's faces class action lawsuit in US court  Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less